Web Results

en.wikipedia.org/wiki/Vorinostat

Vorinostat (rINN) also known as suberanilohydroxamic acid is a member of a larger class of compounds that inhibit histone deacetylases (HDAC).

aidsinfo.nih.gov/drugs/529/vorinostat/0/patient

Drug information on Vorinostat for patients and consumers.

chemocare.com/chemotherapy/drug-info/Vorinostat.aspx

Vorinostat (Zolinza) chemotherapy side effects, how it's given, how it works, precautions and self care tips for treatment of cutaneous T-cell lymphoma.

www.cancer.gov/about-cancer/treatment/drugs/fda-vorinostat

Jul 3, 2013 ... On October 6, 2006, the U.S. Food and Drug Administration granted approval to vorinostat (Zolinza™, Merck & Co., Inc.), a histone deacetylase ...

www.selleckchem.com/products/Vorinostat-saha.html

Vorinostat also known as SAHA, Zolinza, MK-0683 is an HDAC inhibitor. Vorinostat CAS No 149647-78-9 with purity >99% & solubility DMSO is available.

www.rxlist.com/zolinza-drug.htm

Jun 16, 2017 ... Vorinostat is a white to light orange powder. It is very slightly soluble in water, slightly soluble in ethanol, isopropanol and acetone, freely ...

www.oncolink.org/cancer-treatment/chemotherapy/oncolink-rx/vorinostat-zolinza-r

Sep 28, 2017 ... Vorinostat is in a class of anti-cancer therapies called histone deacetylase ( HDAC) inhibitors. Histone deacetylation is a biochemical process ...

www.nature.com/bjc/journal/v95/n1s/full/6603463a.html

Dec 12, 2006 ... Vorinostat (suberoylanilide hydroxamic acid or SAHA) is a nanomolar inhibitor of HDAC activity that has undergone initial evaluation in multiple ...

www.medscape.com/viewarticle/722524_3

Vorinostat is a member of the hydroxamic acid subclass of histone deacetylase ( HDAC) inhibitors. Its primary biochemical mechanism is to correct an aberrant ...